Literature DB >> 11146149

Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates.

F Y Hsieh1, P W Lavori.   

Abstract

This paper derives a formula to calculate the number of deaths required for a proportional hazards regression model with a nonbinary covariate. The method does not require assumptions about the distributions of survival time and predictor variables other than proportional hazards. Simulations show that the censored observations do not contribute to the power of the test in the proportional hazards model, a fact that is well known for a binary covariate. This paper also provides a variance inflation factor together with simulations for adjustment of sample size when additional covariates are included in the model. Control Clin Trials 2000;21:552-560

Entities:  

Mesh:

Year:  2000        PMID: 11146149     DOI: 10.1016/s0197-2456(00)00104-5

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  101 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

3.  Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort.

Authors:  William S Oetting; David P Schladt; Robert E Leduc; Pamala A Jacobson; Weihua Guan; Arthur J Matas; Ajay Israni
Journal:  Transpl Int       Date:  2011-09-29       Impact factor: 3.782

4.  Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Steven E Kahn; Paul W Franks; Dana Dabelea; Richard F Hamman; William C Knowler; David M Nathan; David Altshuler
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

5.  Sample size evaluation for a multiply matched case-control study using the score test from a conditional logistic (discrete Cox PH) regression model.

Authors:  John M Lachin
Journal:  Stat Med       Date:  2008-06-30       Impact factor: 2.373

6.  Sample size requirements for training high-dimensional risk predictors.

Authors:  Kevin K Dobbin; Xiao Song
Journal:  Biostatistics       Date:  2013-07-19       Impact factor: 5.899

7.  Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Authors:  Sheng Han; Xiang Li; Bo Qiu; Tao Jiang; Anhua Wu
Journal:  J Neurooncol       Date:  2015-05-26       Impact factor: 4.130

8.  Offspring Socioeconomic Status and Parent Mortality Within a Historical Population.

Authors:  Zachary Zimmer; Heidi A Hanson; Ken R Smith
Journal:  Demography       Date:  2016-10

Review 9.  STRATOS guidance document on measurement error and misclassification of variables in observational epidemiology: Part 1-Basic theory and simple methods of adjustment.

Authors:  Ruth H Keogh; Pamela A Shaw; Paul Gustafson; Raymond J Carroll; Veronika Deffner; Kevin W Dodd; Helmut Küchenhoff; Janet A Tooze; Michael P Wallace; Victor Kipnis; Laurence S Freedman
Journal:  Stat Med       Date:  2020-04-03       Impact factor: 2.373

10.  A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease.

Authors:  Themistocles L Assimes; Joshua W Knowles; James R Priest; Analabha Basu; Astrid Borchert; Kelly A Volcik; Megan L Grove; Holly K Tabor; Audrey Southwick; Raymond Tabibiazar; Steve Sidney; Eric Boerwinkle; Alan S Go; Carlos Iribarren; Mark A Hlatky; Stephen P Fortmann; Richard M Myers; Hartmut Kuhn; Neil Risch; Thomas Quertermous
Journal:  Atherosclerosis       Date:  2007-10-23       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.